Zai Lab and Pfizer announced a strategic collaboration for Xacduro (sulbactam-durlobactam) in mainland China – Zai Lab + Pfizer
Zai Lab and Pfizer announced a strategic collaboration for the novel antibacterial drug Xacduro (sulbactam-durlobactam) in mainland China. Pfizer’s affiliated companies will be exclusively authorized to undertake and… read more.
